Terns Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Terns Pharmaceuticals, a clinical-stage biopharmaceutical company focusing on serious diseases like NASH and obesity, will present at the 21st Annual Needham Virtual Healthcare Conference.

The presentation is scheduled for April 11, 2022, at 2:15 p.m. ET. Investors can access a live audio webcast via Terns' investor relations webpage, with a replay available for 30 days post-event.

Terns is developing a diverse pipeline of therapies, including an FXR agonist and a VAP-1 inhibitor.

FOSTER CITY, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates to address serious diseases such as non-alcoholic steatohepatitis (NASH) and obesity, today announced that management will be presenting at the 21^st Annual Needham Virtual Healthcare Conference on Monday, April 11 at 2:15 p.m. ET.

A live audio webcast of the presentation will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcast will be archived on Terns’ website for 30 days following the presentation.

About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates to address serious diseases such as NASH and obesity. Terns’ pipeline includes three clinical stage development programs including an FXR agonist, a VAP-1 inhibitor and a THR-β agonist, and a preclinical small-molecule GLP-1 receptor agonist program. For more information, please visit: www.ternspharma.com.

Contacts for Terns

Investors
Justin Ng
investors@ternspharma.com

Media
Jenna Urban
Berry & Company Public Relations
media@ternspharma.com

FAQ

What is Terns Pharmaceuticals presenting at the Needham Virtual Healthcare Conference?

Terns Pharmaceuticals will present its clinical developments and pipeline strategies at the 21st Annual Needham Virtual Healthcare Conference on April 11, 2022.

When is Terns Pharmaceuticals' presentation at the Needham Conference?

The presentation by Terns Pharmaceuticals is scheduled for April 11, 2022, at 2:15 p.m. ET.

How can I watch Terns Pharmaceuticals' presentation?

You can watch Terns Pharmaceuticals' presentation live via their investor relations page, and a replay will be available for 30 days afterward.

What diseases is Terns Pharmaceuticals focusing on?

Terns Pharmaceuticals focuses on developing treatments for serious diseases such as non-alcoholic steatohepatitis (NASH) and obesity.

What types of therapies is Terns Pharmaceuticals developing?

Terns Pharmaceuticals is developing small-molecule single-agent and combination therapies, including an FXR agonist and a VAP-1 inhibitor.